Skip Navigation
Department of Health and Human Services
Slide Tray
0 slides

Return to Slide Library


Add Presentation to Slide Tray Presentation:

Treatment Options for Attention Deficit Hyperactivity Disorder

Slide: 20 of 31

Adverse Effects (3 of 3)

GXR was not well tolerated in studies, with less than 20 percent of participants completing the studies at 12 months. Adverse effects include somnolence or sedation, fatigue, headache, and possible weight gain. Abnormal or worsening electrocardiographic changes judged clinically significant in 1 percent of patients suggest that monitoring of cardiac status is indicated.